Back to search

Article

Alternative back-splicing of circular RNAs modulates almonertinib resistance in non-small cell lung cancer

2026-05-21

Abstract excerpt

<title>Abstract</title> <p>Acquired resistance to third-generation EGFR tyrosine kinase inhibitors (TKIs) such as almonertinib presents a major clinical challenge in non-small cell lung cancer (NSCLC). Circular RNAs (circRNAs) are generated via back-splicing, and are versatile players in cancer biology. By using long-read nanopore sequencing, we profiled full-length circRNAs in almonertinib-resistant NSCLC cells...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d7dd42b5-dd3d-5d1d-baa6-7c7266112dff
DOI
10.21203/rs.3.rs-9505749/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alternative back-splicing of circular RNAs modulates almonertinib resistance in non-small cell lung cancerDOI 10.21203/rs.3.rs-9505749/v1
Select a neighboring publication to make it the new centre.